Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New antibiotic U-64846: fermentation, isolation and characterization.

L A Dolak, T M Castle, B R Hannon

    The Journal of Antibiotics
    |February 1, 1984
    PubMed
    Summary

    A novel antibiotic, U-64846, produced by Streptomyces braegensis, exhibits potent activity against Gram-positive bacteria. Its unique chemical structure suggests it is unrelated to existing antibiotic classes.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Carbon-carbon-linked (pyrazolylphenyl)oxazolidinones with antibacterial activity against multiple drug resistant gram-positive and fastidious gram-negative bacteria.

    Bioorganic & medicinal chemistry·2001
    Same author

    Identification of novel potent hydroxamic acid inhibitors of peptidyl deformylase and the importance of the hydroxamic acid functionality on inhibition.

    Bioorganic & medicinal chemistry letters·2001
    Same author

    Tipranavir (PNU-140690): a potent, orally bioavailable nonpeptidic HIV protease inhibitor of the 5,6-dihydro-4-hydroxy-2-pyrone sulfonamide class.

    Journal of medicinal chemistry·1998
    Same author

    (-)-6-Chloro-2-[(1-furo[2, 3-c]pyridin-5-ylethyl)thio]-4-pyrimidinamine, PNU-142721, a new broad spectrum HIV-1 non-nucleoside reverse transcriptase inhibitor.

    Journal of medicinal chemistry·1998
    Same author

    Structure-based design of nonpeptidic HIV protease inhibitors: the sulfonamide-substituted cyclooctylpyramones.

    Journal of medicinal chemistry·1997
    Same author

    Synthesis and biological activities of (R)-5,6-dihydro-N,N-dimethyl-4H-imidazo[4,5,1-ij]quinolin-5-amine and its metabolites.

    Journal of medicinal chemistry·1997

    Area of Science:

    • Microbiology
    • Organic Chemistry
    • Pharmacology

    Background:

    • The continuous emergence of antibiotic-resistant bacteria necessitates the discovery of novel antimicrobial agents.
    • Streptomyces species are a prolific source of diverse bioactive compounds, including antibiotics.

    Purpose of the Study:

    • To characterize a newly isolated antibiotic, designated U-64846, produced by Streptomyces braegensis.
    • To determine the chemical properties, antibacterial spectrum, and structural uniqueness of U-64846.

    Main Methods:

    • Isolation and purification of antibiotic U-64846 from Streptomyces braegensis culture.
    • Determination of physicochemical properties including solubility, stability, and molecular formula (C18H35C1N4O9).
    • Spectroscopic analysis (1H NMR, 13C NMR, IR, UV) and acidic hydrolysis to elucidate structural features.

    Main Results:

    • Antibiotic U-64846 is a reddish, water-soluble solid, air-sensitive, and decomposes above 300°C.
    • The antibiotic demonstrated inhibitory activity against a range of Gram-positive bacteria.
    • Acidic hydrolysis yielded 3,7-diaminoheptanoic acid, and spectroscopic data indicated a novel chemical structure distinct from known antibiotic families.

    Conclusions:

    • Antibiotic U-64846 represents a new chemical entity with significant potential as an antibacterial agent.
    • The unique structure of U-64846 warrants further investigation for its mechanism of action and therapeutic applications.
    • Discovery of U-64846 highlights the ongoing importance of microbial natural products in the search for new antibiotics.

    Related Experiment Videos